SUPN

Supernus Pharmaceuticals, Inc.

50.06

USD

SUPN Earnings Reports

Positive Surprise Ratio

SUPN beat 30 of 41 last estimates.

73%

Next Report

Date of Next Report

May 04, 2026

Estimate for Q1 26 (Revenue/ EPS)

$196.82M

$0.50

Implied change from Q4 25 (Revenue/ EPS)

-6.97%

-40.48%

Implied change from Q1 25 (Revenue/ EPS)

+31.37%

+13.64%

Supernus Pharmaceuticals, Inc. earnings per share and revenue

On Feb 24, 2026, SUPN reported earnings of 0.84 USD per share (EPS) for Q4 25, beating the estimate of 0.34 USD, resulting in a 142.21% surprise. Revenue reached 211.57 million, compared to an expected 198.90 million, with a 6.37% difference. The market reacted with a +5.67% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 6 analysts forecast an EPS of 0.50 USD, with revenue projected to reach 196.82 million USD, implying an decrease of -40.48% EPS, and decrease of -6.97% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Taysha Gene Therapies, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.09

Actual

-$0.08

Surprise

+18.45%

Assembly Biosciences, Inc

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.66

Actual

$2.48

Surprise

+474.06%

Sol-Gel Technologies Ltd. Ordinary Shares

Report Date

Mar 23, 2026 For Q4 25

Estimate

$0.39

Actual

Surprise

FAQ

What were Supernus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Supernus Pharmaceuticals, Inc. reported EPS of $0.84, beating estimates by 142.21%, and revenue of $211.57M, 6.37% above expectations.

How did the market react to Supernus Pharmaceuticals, Inc.'s Q4 2025 earnings?

The stock price moved up 5.67%, changed from $53.30 before the earnings release to $56.32 the day after.

When is Supernus Pharmaceuticals, Inc. expected to report next?

The next earning report is scheduled for May 04, 2026.

What are the forecasts for Supernus Pharmaceuticals, Inc.'s next earnings report?

Based on 6 analysts, Supernus Pharmaceuticals, Inc. is expected to report EPS of $0.50 and revenue of $196.82M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.